USES SKYRIZI is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using …

Jun 18, 2024 · The most common side effects of SKYRIZI in people treated for Crohn's disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach …

Jul 23, 2024 · As a treatment for ulcerative colitis, Skyrizi works by fighting the inflammation that can lead to symptoms of the disease.

May 8, 2025 · What is the best medicine for ulcerative colitis? The treatment options for ulcerative colitis vary based on the disease’s severity and can be categorized into six main types: …

Nov 8, 2025 · Yes, SKYRIZI is used for ulcerative colitis. Learn about its recent FDA approval, how this IL-23 inhibitor works, and what clinical studies show about its effectiveness for …

Jun 19, 2024 · The US Food and Drug Administration (FDA) has approved Skyrizi (risankizumab-rzaa; AbbVie) for the treatment of moderately to severely active ulcerative colitis in adults. This …

SKYRIZI® is indicated for the treatment of moderately to severely active ulcerative colitis in adults. See Important Safety and Prescribing Information.

Patients should be evaluated for tuberculosis (TB) prior to starting this medication, and should not be given Skyrizi® if there is active TB. If there is a hypersensitivity reaction or anaphylaxis …

Jun 20, 2024 · The FDA has given its okay to the biologic drug Skyrizi (risankizumab) as a treatment for people with moderately to severely active ulcerative colitis. The medication works …

Skyrizi (risankizumab-rzaa) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderately to severely active Crohn’s disease in adults. It’s also …